Cannabis Science, Inc. is researching on cannabis-based medicines and products. The company is also working on research and development in medical marijuana.

Cannabis Science Inc a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.

Cannabis Science, Inc. (otcqb:CBIS) announced in late April the initiation of preclinical development characterization of CS-TATI-I following the execution of contractual retention of vendor labs located in the Amsterdam Life Science Cluster.

SmartOTC brings a special trend analysis of these stocks: Applied DNA Sciences Inc (OTCBB:APDN), TagLikeMe Corp (OTCMKTS:TAGG), Cannabis Science Inc (OTCMKTS:CBIS), Advaxis, Inc. (OTCBB:ADXS). Applied DNA Sciences Inc (OTCBB:APDN) ...

AMSTERDAM, April 26, 2013 /PRNewswire/ -- Cannabis Science, Inc. (OTC: CBIS) announced today the initiation of preclinical development characterization of CS-TATI-I following the execution of contractual retention of vendor labs located in the ...

Cannabis Science, Inc. (CBIS) announced the initiation of preclinical development characterization of CS-TATI-I following the execution of contractual retention of vendor labs located in the Amsterdam Life Science Cluster.

Cannabis Science Inc. is researching on cannabis-based medicines and products. The company is also working on research and development in medical marijuana.

Cannabis Science Inc a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.

Cannabis Science, Inc. is researching on cannabis-based medicines and products. The company is also working on research and development in medical marijuana.

Cannabis Science Inc (OTCMKTS:CBIS) decreased -2.02% and closed at $0.0485 on a traded volume of 1.50 million shares, in comparison to 3.66 million shares of average trading volume.